Patent · US Active

NLRP3 modulators

US11072612B2 · kind B2 · utility

1Cited by

2References

5Claims

0Family size

Assignee

Innate Tumor Immunity, Inc. · US

Inventors

Gary D. Glick · Ann Arbor, US
Shomir Ghosh · Brookline, US
William R. Roush · West Jupiter, US
Edward J. Olhava · Newton, US

Key dates

Filing date	Dec 5, 2019
Grant date	Jul 27, 2021
Priority date	—
Expiry date	Dec 5, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure features compounds of Formula I, or a pharmaceutically acceptable salt thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.